CITADEL ADVISORS LLC
Top Portfolio Positions
4,239 positions ·
$547,092,820,445 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| SPY |
Spdr S&P 500 ETF Trust
|
64,565,975 | $41,989,836,181 | 7.68% |
| QQQ |
Invesco Qqq Trust, Series 1
|
55,171,964 | $31,844,154,181 | 5.82% |
| NVDA |
Nvidia Corp
Technology
|
137,243,161 | $23,935,207,278 | 4.37% |
| TSLA |
Tesla, Inc.
Consumer Cyclical
|
63,922,509 | $23,763,192,720 | 4.34% |
| GLD |
Spdr Gold Trust
|
34,441,722 | $14,819,928,559 | 2.71% |
| AAPL |
Apple Inc.
Technology
|
55,393,070 | $14,058,207,235 | 2.57% |
| META |
Meta Platforms, Inc.
Communication Services
|
23,967,037 | $13,712,260,878 | 2.51% |
| MSFT |
Microsoft Corp
Technology
|
32,176,424 | $11,910,746,871 | 2.18% |
| AMZN |
Amazon Com Inc
Consumer Cyclical
|
51,582,437 | $10,743,074,153 | 1.96% |
| MU |
Micron Technology Inc
Technology
|
31,629,772 | $10,685,802,171 | 1.95% |
Portfolio Trend
Holdings in FVCB
Shares Held
Position Value (USD)
13 of 13 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $568,683 | 37,438 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $487,447 | 35,043 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $413,561 | 31,886 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $523,152 | 44,335 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $402,759 | 38,104 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $10,570 | 1,000 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $1,057 | 100 | Call | Defined | 2025-05-15 | |
| 2024-12-31 | $377,577 | 30,038 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $279,700 | 21,433 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $2,610 | 200 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $253,835 | 23,245 | Shares | Defined | 2024-08-14 | |
| 2022-03-31 | $357,265 | 21,522 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $99,092 | 6,294 | Shares | Defined | 2022-02-14 | |
| No quarters match your search. | ||||||